IV JORNADAS DE IV JORNADAS DE SENSIBILIZACIOacuteN ANTE LA SENSIBILIZACIOacuteN ANTE LA
DISCAPACIDAD DISCAPACIDAD
Rosa Corbiacute Llopis
Huelva 25 de noviembre 2009
El pasado de la FQEl pasado de la FQNintildeos embrujados con sabor
salado
En que consiste la Fibrosis En que consiste la Fibrosis QuiacutesticaQuiacutestica
- Enfermedad hereditaria - Afectacioacuten de las glaacutendulas
exocrinas - Siacutentomas fundamentales
Diarrea persistente desnutricioacuten
Tos croacutenica con mucosidad espesa
Deshidratacioacuten
- Otros signos y siacutentomas
Diabetes mellitus
Alteracioacuten hepaacuteticaCirrosis
Sinusitis
Colelitiasis
Esterilidad
-
1989 gen de la FQ en el cromosoma 7
Muacuteltiples mutaciones F508
Incidencia 12500-4000 RN
Herencia autosoacutemica recesiva
Portadores 125-30
Test de sudor cloro y sodio
Estudio geneacutetico
Tripsina inmunorreactiva
(screening neonatal)
DiagnoacutesticoDiagnoacutestico
PrevencioacutenPrevencioacuten
FISIOTERAPIA RESPIRATORIA AEROSOLTERAPIAENZIMAS PANCREATICAS SUPLEMENTOS
VITAMIacuteNICOS ANTIBIOacuteTICOS
OXIGENOTERAPIA
TRASPLANTE BIPULMONAR HEPAacuteTICO
NUTRICIOacuteN ENTERAL
DISCAPACIDAD FIacuteSICA PROGRESIVAPOR
ENFERMEDAD ORGAacuteNICA CROacuteNICA
Supervivencia mediaSupervivencia media
Investigacioacuten Investigacioacuten meacutedicameacutedica
Chest 2009 May135(5)1223-32Efficacy and safety of inhaled aztreonam lysine for airway pseudomonas in cystic fibrosisRetsch-Bogart GZ Quittner AL Gibson RL Oermann CM McCoy KS Montgomery AB Cooper PJDepartment of Pediatrics University of North Carolina Chapel Hill NC 27599-7217 USA gzrbmeduncedu
Drugs 200969(14)1903-10 doi 10216511318500Emerging treatments in cystic fibrosisJones AM Helm JM
Expert Opin Biol Ther 2009 Aug9(8)991-1003Non-viral vectors in cystic fibrosis gene therapy recent developments and future prospectsPringle IA Hyde SC Gill DRUniversity of Oxford John Radcliffe Hospital Nuffield Department of Clinical Laboratory Sciences Oxford UK ianpringletrinityoxacuk
Tuacute respiras sin pensar Yo yo no pienso maacutes que en respirar
wwwfqandaluciaorgwwwfqandaluciaorg
El pasado de la FQEl pasado de la FQNintildeos embrujados con sabor
salado
En que consiste la Fibrosis En que consiste la Fibrosis QuiacutesticaQuiacutestica
- Enfermedad hereditaria - Afectacioacuten de las glaacutendulas
exocrinas - Siacutentomas fundamentales
Diarrea persistente desnutricioacuten
Tos croacutenica con mucosidad espesa
Deshidratacioacuten
- Otros signos y siacutentomas
Diabetes mellitus
Alteracioacuten hepaacuteticaCirrosis
Sinusitis
Colelitiasis
Esterilidad
-
1989 gen de la FQ en el cromosoma 7
Muacuteltiples mutaciones F508
Incidencia 12500-4000 RN
Herencia autosoacutemica recesiva
Portadores 125-30
Test de sudor cloro y sodio
Estudio geneacutetico
Tripsina inmunorreactiva
(screening neonatal)
DiagnoacutesticoDiagnoacutestico
PrevencioacutenPrevencioacuten
FISIOTERAPIA RESPIRATORIA AEROSOLTERAPIAENZIMAS PANCREATICAS SUPLEMENTOS
VITAMIacuteNICOS ANTIBIOacuteTICOS
OXIGENOTERAPIA
TRASPLANTE BIPULMONAR HEPAacuteTICO
NUTRICIOacuteN ENTERAL
DISCAPACIDAD FIacuteSICA PROGRESIVAPOR
ENFERMEDAD ORGAacuteNICA CROacuteNICA
Supervivencia mediaSupervivencia media
Investigacioacuten Investigacioacuten meacutedicameacutedica
Chest 2009 May135(5)1223-32Efficacy and safety of inhaled aztreonam lysine for airway pseudomonas in cystic fibrosisRetsch-Bogart GZ Quittner AL Gibson RL Oermann CM McCoy KS Montgomery AB Cooper PJDepartment of Pediatrics University of North Carolina Chapel Hill NC 27599-7217 USA gzrbmeduncedu
Drugs 200969(14)1903-10 doi 10216511318500Emerging treatments in cystic fibrosisJones AM Helm JM
Expert Opin Biol Ther 2009 Aug9(8)991-1003Non-viral vectors in cystic fibrosis gene therapy recent developments and future prospectsPringle IA Hyde SC Gill DRUniversity of Oxford John Radcliffe Hospital Nuffield Department of Clinical Laboratory Sciences Oxford UK ianpringletrinityoxacuk
Tuacute respiras sin pensar Yo yo no pienso maacutes que en respirar
wwwfqandaluciaorgwwwfqandaluciaorg
En que consiste la Fibrosis En que consiste la Fibrosis QuiacutesticaQuiacutestica
- Enfermedad hereditaria - Afectacioacuten de las glaacutendulas
exocrinas - Siacutentomas fundamentales
Diarrea persistente desnutricioacuten
Tos croacutenica con mucosidad espesa
Deshidratacioacuten
- Otros signos y siacutentomas
Diabetes mellitus
Alteracioacuten hepaacuteticaCirrosis
Sinusitis
Colelitiasis
Esterilidad
-
1989 gen de la FQ en el cromosoma 7
Muacuteltiples mutaciones F508
Incidencia 12500-4000 RN
Herencia autosoacutemica recesiva
Portadores 125-30
Test de sudor cloro y sodio
Estudio geneacutetico
Tripsina inmunorreactiva
(screening neonatal)
DiagnoacutesticoDiagnoacutestico
PrevencioacutenPrevencioacuten
FISIOTERAPIA RESPIRATORIA AEROSOLTERAPIAENZIMAS PANCREATICAS SUPLEMENTOS
VITAMIacuteNICOS ANTIBIOacuteTICOS
OXIGENOTERAPIA
TRASPLANTE BIPULMONAR HEPAacuteTICO
NUTRICIOacuteN ENTERAL
DISCAPACIDAD FIacuteSICA PROGRESIVAPOR
ENFERMEDAD ORGAacuteNICA CROacuteNICA
Supervivencia mediaSupervivencia media
Investigacioacuten Investigacioacuten meacutedicameacutedica
Chest 2009 May135(5)1223-32Efficacy and safety of inhaled aztreonam lysine for airway pseudomonas in cystic fibrosisRetsch-Bogart GZ Quittner AL Gibson RL Oermann CM McCoy KS Montgomery AB Cooper PJDepartment of Pediatrics University of North Carolina Chapel Hill NC 27599-7217 USA gzrbmeduncedu
Drugs 200969(14)1903-10 doi 10216511318500Emerging treatments in cystic fibrosisJones AM Helm JM
Expert Opin Biol Ther 2009 Aug9(8)991-1003Non-viral vectors in cystic fibrosis gene therapy recent developments and future prospectsPringle IA Hyde SC Gill DRUniversity of Oxford John Radcliffe Hospital Nuffield Department of Clinical Laboratory Sciences Oxford UK ianpringletrinityoxacuk
Tuacute respiras sin pensar Yo yo no pienso maacutes que en respirar
wwwfqandaluciaorgwwwfqandaluciaorg
1989 gen de la FQ en el cromosoma 7
Muacuteltiples mutaciones F508
Incidencia 12500-4000 RN
Herencia autosoacutemica recesiva
Portadores 125-30
Test de sudor cloro y sodio
Estudio geneacutetico
Tripsina inmunorreactiva
(screening neonatal)
DiagnoacutesticoDiagnoacutestico
PrevencioacutenPrevencioacuten
FISIOTERAPIA RESPIRATORIA AEROSOLTERAPIAENZIMAS PANCREATICAS SUPLEMENTOS
VITAMIacuteNICOS ANTIBIOacuteTICOS
OXIGENOTERAPIA
TRASPLANTE BIPULMONAR HEPAacuteTICO
NUTRICIOacuteN ENTERAL
DISCAPACIDAD FIacuteSICA PROGRESIVAPOR
ENFERMEDAD ORGAacuteNICA CROacuteNICA
Supervivencia mediaSupervivencia media
Investigacioacuten Investigacioacuten meacutedicameacutedica
Chest 2009 May135(5)1223-32Efficacy and safety of inhaled aztreonam lysine for airway pseudomonas in cystic fibrosisRetsch-Bogart GZ Quittner AL Gibson RL Oermann CM McCoy KS Montgomery AB Cooper PJDepartment of Pediatrics University of North Carolina Chapel Hill NC 27599-7217 USA gzrbmeduncedu
Drugs 200969(14)1903-10 doi 10216511318500Emerging treatments in cystic fibrosisJones AM Helm JM
Expert Opin Biol Ther 2009 Aug9(8)991-1003Non-viral vectors in cystic fibrosis gene therapy recent developments and future prospectsPringle IA Hyde SC Gill DRUniversity of Oxford John Radcliffe Hospital Nuffield Department of Clinical Laboratory Sciences Oxford UK ianpringletrinityoxacuk
Tuacute respiras sin pensar Yo yo no pienso maacutes que en respirar
wwwfqandaluciaorgwwwfqandaluciaorg
Test de sudor cloro y sodio
Estudio geneacutetico
Tripsina inmunorreactiva
(screening neonatal)
DiagnoacutesticoDiagnoacutestico
PrevencioacutenPrevencioacuten
FISIOTERAPIA RESPIRATORIA AEROSOLTERAPIAENZIMAS PANCREATICAS SUPLEMENTOS
VITAMIacuteNICOS ANTIBIOacuteTICOS
OXIGENOTERAPIA
TRASPLANTE BIPULMONAR HEPAacuteTICO
NUTRICIOacuteN ENTERAL
DISCAPACIDAD FIacuteSICA PROGRESIVAPOR
ENFERMEDAD ORGAacuteNICA CROacuteNICA
Supervivencia mediaSupervivencia media
Investigacioacuten Investigacioacuten meacutedicameacutedica
Chest 2009 May135(5)1223-32Efficacy and safety of inhaled aztreonam lysine for airway pseudomonas in cystic fibrosisRetsch-Bogart GZ Quittner AL Gibson RL Oermann CM McCoy KS Montgomery AB Cooper PJDepartment of Pediatrics University of North Carolina Chapel Hill NC 27599-7217 USA gzrbmeduncedu
Drugs 200969(14)1903-10 doi 10216511318500Emerging treatments in cystic fibrosisJones AM Helm JM
Expert Opin Biol Ther 2009 Aug9(8)991-1003Non-viral vectors in cystic fibrosis gene therapy recent developments and future prospectsPringle IA Hyde SC Gill DRUniversity of Oxford John Radcliffe Hospital Nuffield Department of Clinical Laboratory Sciences Oxford UK ianpringletrinityoxacuk
Tuacute respiras sin pensar Yo yo no pienso maacutes que en respirar
wwwfqandaluciaorgwwwfqandaluciaorg
PrevencioacutenPrevencioacuten
FISIOTERAPIA RESPIRATORIA AEROSOLTERAPIAENZIMAS PANCREATICAS SUPLEMENTOS
VITAMIacuteNICOS ANTIBIOacuteTICOS
OXIGENOTERAPIA
TRASPLANTE BIPULMONAR HEPAacuteTICO
NUTRICIOacuteN ENTERAL
DISCAPACIDAD FIacuteSICA PROGRESIVAPOR
ENFERMEDAD ORGAacuteNICA CROacuteNICA
Supervivencia mediaSupervivencia media
Investigacioacuten Investigacioacuten meacutedicameacutedica
Chest 2009 May135(5)1223-32Efficacy and safety of inhaled aztreonam lysine for airway pseudomonas in cystic fibrosisRetsch-Bogart GZ Quittner AL Gibson RL Oermann CM McCoy KS Montgomery AB Cooper PJDepartment of Pediatrics University of North Carolina Chapel Hill NC 27599-7217 USA gzrbmeduncedu
Drugs 200969(14)1903-10 doi 10216511318500Emerging treatments in cystic fibrosisJones AM Helm JM
Expert Opin Biol Ther 2009 Aug9(8)991-1003Non-viral vectors in cystic fibrosis gene therapy recent developments and future prospectsPringle IA Hyde SC Gill DRUniversity of Oxford John Radcliffe Hospital Nuffield Department of Clinical Laboratory Sciences Oxford UK ianpringletrinityoxacuk
Tuacute respiras sin pensar Yo yo no pienso maacutes que en respirar
wwwfqandaluciaorgwwwfqandaluciaorg
FISIOTERAPIA RESPIRATORIA AEROSOLTERAPIAENZIMAS PANCREATICAS SUPLEMENTOS
VITAMIacuteNICOS ANTIBIOacuteTICOS
OXIGENOTERAPIA
TRASPLANTE BIPULMONAR HEPAacuteTICO
NUTRICIOacuteN ENTERAL
DISCAPACIDAD FIacuteSICA PROGRESIVAPOR
ENFERMEDAD ORGAacuteNICA CROacuteNICA
Supervivencia mediaSupervivencia media
Investigacioacuten Investigacioacuten meacutedicameacutedica
Chest 2009 May135(5)1223-32Efficacy and safety of inhaled aztreonam lysine for airway pseudomonas in cystic fibrosisRetsch-Bogart GZ Quittner AL Gibson RL Oermann CM McCoy KS Montgomery AB Cooper PJDepartment of Pediatrics University of North Carolina Chapel Hill NC 27599-7217 USA gzrbmeduncedu
Drugs 200969(14)1903-10 doi 10216511318500Emerging treatments in cystic fibrosisJones AM Helm JM
Expert Opin Biol Ther 2009 Aug9(8)991-1003Non-viral vectors in cystic fibrosis gene therapy recent developments and future prospectsPringle IA Hyde SC Gill DRUniversity of Oxford John Radcliffe Hospital Nuffield Department of Clinical Laboratory Sciences Oxford UK ianpringletrinityoxacuk
Tuacute respiras sin pensar Yo yo no pienso maacutes que en respirar
wwwfqandaluciaorgwwwfqandaluciaorg
Supervivencia mediaSupervivencia media
Investigacioacuten Investigacioacuten meacutedicameacutedica
Chest 2009 May135(5)1223-32Efficacy and safety of inhaled aztreonam lysine for airway pseudomonas in cystic fibrosisRetsch-Bogart GZ Quittner AL Gibson RL Oermann CM McCoy KS Montgomery AB Cooper PJDepartment of Pediatrics University of North Carolina Chapel Hill NC 27599-7217 USA gzrbmeduncedu
Drugs 200969(14)1903-10 doi 10216511318500Emerging treatments in cystic fibrosisJones AM Helm JM
Expert Opin Biol Ther 2009 Aug9(8)991-1003Non-viral vectors in cystic fibrosis gene therapy recent developments and future prospectsPringle IA Hyde SC Gill DRUniversity of Oxford John Radcliffe Hospital Nuffield Department of Clinical Laboratory Sciences Oxford UK ianpringletrinityoxacuk
Tuacute respiras sin pensar Yo yo no pienso maacutes que en respirar
wwwfqandaluciaorgwwwfqandaluciaorg
Investigacioacuten Investigacioacuten meacutedicameacutedica
Chest 2009 May135(5)1223-32Efficacy and safety of inhaled aztreonam lysine for airway pseudomonas in cystic fibrosisRetsch-Bogart GZ Quittner AL Gibson RL Oermann CM McCoy KS Montgomery AB Cooper PJDepartment of Pediatrics University of North Carolina Chapel Hill NC 27599-7217 USA gzrbmeduncedu
Drugs 200969(14)1903-10 doi 10216511318500Emerging treatments in cystic fibrosisJones AM Helm JM
Expert Opin Biol Ther 2009 Aug9(8)991-1003Non-viral vectors in cystic fibrosis gene therapy recent developments and future prospectsPringle IA Hyde SC Gill DRUniversity of Oxford John Radcliffe Hospital Nuffield Department of Clinical Laboratory Sciences Oxford UK ianpringletrinityoxacuk
Tuacute respiras sin pensar Yo yo no pienso maacutes que en respirar
wwwfqandaluciaorgwwwfqandaluciaorg
Chest 2009 May135(5)1223-32Efficacy and safety of inhaled aztreonam lysine for airway pseudomonas in cystic fibrosisRetsch-Bogart GZ Quittner AL Gibson RL Oermann CM McCoy KS Montgomery AB Cooper PJDepartment of Pediatrics University of North Carolina Chapel Hill NC 27599-7217 USA gzrbmeduncedu
Drugs 200969(14)1903-10 doi 10216511318500Emerging treatments in cystic fibrosisJones AM Helm JM
Expert Opin Biol Ther 2009 Aug9(8)991-1003Non-viral vectors in cystic fibrosis gene therapy recent developments and future prospectsPringle IA Hyde SC Gill DRUniversity of Oxford John Radcliffe Hospital Nuffield Department of Clinical Laboratory Sciences Oxford UK ianpringletrinityoxacuk
Tuacute respiras sin pensar Yo yo no pienso maacutes que en respirar
wwwfqandaluciaorgwwwfqandaluciaorg
Tuacute respiras sin pensar Yo yo no pienso maacutes que en respirar
wwwfqandaluciaorgwwwfqandaluciaorg
wwwfqandaluciaorgwwwfqandaluciaorg
Top Related